Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

Anaveon appoints Biotech Leader Thaminda Ramanayake as Chief Executive Officer

BASEL, Switzerland, March 23, 2026 (GLOBE NEWSWIRE) -- Anaveon, a late-stage preclinical biotech focused on reprogramming the immune system with precision biologics, announces today the appointment of Thaminda Ramanayake as its new Chief Executive Officer. Mr. Ramanayake brings over 20 years of global biopharmaceutical leadership experience, with a strong track record in business development, strategic transactions, and advancing innovative ther…

Leadership change - European Biotechnology Magazine

Swiss biotech company Anaveon has appointed a new Chief Executive Officer. As the company announced in March, experienced biopharma executive Thaminda Ramanayake will take over the leadership of the Basel-based firm. The post Leadership change appeared first on European Biotechnology Magazine.